secwatch / observer
8-K filed January 22, 2025, 6:59 PM ET ticker LNZA CIK 0001843724
M&A confidence high sentiment positive materiality 0.75

LanzaTech to spin out LanzaX synthetic biology unit as JV with Tharsis; appoints interim CFO

LanzaTech Global, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Geoff Trukenbrod

Chief Financial Officer
LNZA · LanzaTech Global, Inc.
Effective
2025-01-21
Successor
Justin D. Pugh
Filed
January 22, 2025, 6:59 PM ET
On January 21, 2025, Geoff Trukenbrod, Chief Financial Officer of LanzaTech Global, Inc. (the “Company”), resigned from the Company effective immediately
Appointed (interim)

Justin D. Pugh

interim Chief Financial Officer
LNZA · LanzaTech Global, Inc.
Effective
2025-01-21
Filed
January 22, 2025, 6:59 PM ET
appointed Justin D. Pugh, to serve as interim Chief Financial Officer commencing January 21, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Geoff Trukenbrod resigned as Chief Financial Officer at LanzaTech Global, Inc..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On January 21, 2025, Geoff Trukenbrod, Chief Financial Officer of LanzaTech Global, Inc. (the “Company”), resigned from the Company effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Justin D. Pugh was appointed as interim Chief Financial Officer at LanzaTech Global, Inc..

Action
appointed
Role
interim Chief Financial Officer
Exact text from the filing
appointed Justin D. Pugh, to serve as interim Chief Financial Officer commencing January 21, 2025.
View on SEC.gov

LanzaTech Global, Inc. filing history →

Source: SEC EDGAR
accession 0001628280-25-002081
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.